Enovis Corporation

AI Score

0

Unlock

44.80
-0.55 (-1.21%)
At close: Jan 14, 2025, 3:59 PM
46.98
4.85%
After-hours Jan 14, 2025, 07:37 PM EST
undefined%
Bid 40.17
Market Cap 2.50B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.21
PE Ratio (ttm) -20.27
Forward PE n/a
Analyst Buy
Ask 71.6
Volume 961,231
Avg. Volume (20D) 834,472
Open 45.37
Previous Close 45.35
Day's Range 44.16 - 45.79
52-Week Range 38.27 - 65.03
Beta undefined

About ENOV

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic ev...

IPO Date May 8, 2008
Employees 6,550
Stock Exchange NYSE
Ticker Symbol ENOV

Analyst Forecast

According to 8 analyst ratings, the average rating for ENOV stock is "Buy." The 12-month stock price forecast is $68.5, which is an increase of 52.88% from the latest price.

Buy 75.00%
Hold 12.50%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Enovis Corporation is scheduled to release its earnings on Feb 20, 2025, before market opens.
Analysts project revenue of $554.57M, reflecting a 21.88% YoY growth and earnings per share of 0.91, making a 15.19% increase YoY.
8 months ago · Source
-5.9%
Enovis shares are trading lower. The company repor... Unlock content with Pro Subscription